{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T19:51:44Z","timestamp":1783108304044,"version":"3.54.6"},"reference-count":62,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>In trans women (male-to-female transsexual persons), cross-sex hormone therapy is administered to induce feminization. Breast development is an important part of feminization for most trans women.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Aim<\/jats:title>\n                  <jats:p>The aim of this study is to assess the effect of cross-sex hormone therapy on breast development in adult trans women. Additionally, we aimed to investigate the benefit or harm of administration of progestogens on breast development.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A review of the literature in Embase, Medline, The Cochrane Library, PsycINFO databases, PubMed, and Web of Knowledge until January 2014.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Main Outcome Measures<\/jats:title>\n                  <jats:p>Effects of cross-sex hormone therapy and progestogens on breast development in trans women.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Only few studies with low quality of evidence addressed these topics. The available evidence suggests that breast development is insufficient for the majority of trans women and that type and dosage of hormonal therapy seem not to have an important role on final breast size.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Our knowledge concerning the natural history and effects of different cross-sex hormone therapies on breast development in trans women is extremely sparse and based on low quality of evidence. Current evidence does not provide evidence that progestogens enhance breast development in trans women. Neither do they prove the absence of such an effect. This prevents us from drawing any firm conclusion at this moment and demonstrates the need for further research to clarify these important clinical questions.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1111\/jsm.12487","type":"journal-article","created":{"date-parts":[[2014,3,12]],"date-time":"2014-03-12T08:27:34Z","timestamp":1394612854000},"page":"1240-1247","source":"Crossref","is-referenced-by-count":95,"title":["Clinical Review: Breast Development in Trans Women Receiving Cross-Sex Hormones"],"prefix":"10.1093","volume":"11","author":[{"given":"Katrien","family":"Wierckx","sequence":"first","affiliation":[{"name":"Department of Endocrinology \u00a0 , Ghent , Belgium"},{"name":"Ghent University Hospital \u00a0 , Ghent , Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Gooren","sequence":"additional","affiliation":[{"name":"AndroConsult , ChiangMai , Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"T'Sjoen","sequence":"additional","affiliation":[{"name":"Department of Endocrinology \u00a0 , Ghent , Belgium"},{"name":"Ghent University Hospital \u00a0 , Ghent , Belgium"},{"name":"Department of Sexology and Gender Problems \u00a0 , Ghent , Belgium"},{"name":"Ghent University Hospital \u00a0 , Ghent , Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,5,1]]},"reference":[{"key":"2024032602355535000_bib1","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1210\/jc.2009-0345","article-title":"Endocrine treatment of transsexual persons: an Endocrine Society clinical practice guideline","volume":"94","author":"Hembree","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"2024032602355535000_bib2","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1136\/adc.44.235.291","article-title":"Variations in pattern of pubertal changes in girls","volume":"44","author":"Marshall","year":"1969","journal-title":"Arch Dis Child"},{"key":"2024032602355535000_bib3","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1186\/bcr539","article-title":"Progesterone receptors-animal models and cell signaling in breast cancer: diverse activation pathways for the progesterone receptor: possible implications for breast biology and cancer","volume":"4","author":"Lanari","year":"2002","journal-title":"Breast Cancer Res"},{"key":"2024032602355535000_bib4","article-title":"Hormonal control of breast development","volume-title":"Endocrinology, adult and pediatric","author":"Russo","year":"2010"},{"key":"2024032602355535000_bib5","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1210\/jc.2002-021967","article-title":"Endocrine treatment of transsexual people: a review of treatment regimens, outcomes, and adverse effects","volume":"88","author":"Moore","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2024032602355535000_bib6","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4158\/EP.9.1.12","article-title":"Endocrinologic treatment of gender identity disorders","volume":"9","author":"Tangpricha","year":"2003","journal-title":"Endocr Pract"},{"key":"2024032602355535000_bib7","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1210\/jc.2007-1809","article-title":"Long-term treatment of transsexuals with cross-sex hormones: extensive personal experience","volume":"93","author":"Gooren","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2024032602355535000_bib8","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1056\/NEJMcp1008161","article-title":"Clinical practice: care of transsexual persons","volume":"364","author":"Gooren","year":"2011","journal-title":"N Engl J Med"},{"key":"2024032602355535000_bib9","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1111\/j.1743-6109.2012.02876.x","article-title":"Long-term evaluation of cross-sex hormone treatment in transsexual persons","volume":"9","author":"Wierckx","year":"2012","journal-title":"J Sex Med"},{"key":"2024032602355535000_bib10","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1677\/joe.0.0840371","article-title":"Interaction of spironolactone with oestradiol receptors in cytosol","volume":"84","author":"Levy","year":"1980","journal-title":"J Endocrinol"},{"key":"2024032602355535000_bib11","doi-asserted-by":"crossref","first-page":"29932","DOI":"10.1074\/jbc.M110.131342","article-title":"A new mode of mineralocorticoid receptor antagonism by a potent and selective nonsteroidal molecule","volume":"285","author":"Fagart","year":"2010","journal-title":"J Biol Chem"},{"key":"2024032602355535000_bib12","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1055\/s-2006-925198","article-title":"Effects on the male Endocrine system of long-term treatment with Gonadotropin-releasing hormone agonists and estrogens in male-to-female transsexuals","volume":"38","author":"Mueller","year":"2006","journal-title":"Horm Metab Res"},{"key":"2024032602355535000_bib13","doi-asserted-by":"crossref","first-page":"4422","DOI":"10.1210\/jc.2012-2030","article-title":"Predictive markers for mammoplasty and a comparison of side effect profiles in transwomen taking various hormonal regimens","volume":"97","author":"Seal","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"2024032602355535000_bib14","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1023\/A:1026563806480","article-title":"Medical care of transsexual patients","volume":"4","author":"Oriel","year":"2000","journal-title":"J Gay Lesbian Med Assoc"},{"key":"2024032602355535000_bib15","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/1523-1747.ep12678272","article-title":"Mammogenesis in transsexuals","volume":"63","author":"Orentreich","year":"1974","journal-title":"J Invest Dermatol"},{"key":"2024032602355535000_bib16","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/BF01565538","article-title":"Physical and hormonal evaluation of transsexual patients during hormonal therapy","volume":"10","author":"Meyer","year":"1981","journal-title":"Arch Sex Behav"},{"key":"2024032602355535000_bib17","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/BF01542220","article-title":"Physical and hormonal evaluation of transsexual patients: a longitudinal study","volume":"15","author":"Meyer","year":"1986","journal-title":"Arch Sex Behav"},{"key":"2024032602355535000_bib18","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/BF01579291","article-title":"Sprionolactone with physiological female steroids for presurgical therapy of male-to-female transsexualism","volume":"18","author":"Prior","year":"1989","journal-title":"Arch Sex Behav"},{"key":"2024032602355535000_bib19","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1046\/j.1365-2265.1998.00614.x","article-title":"The effects of oestrogen exposure on bone mass in male to female transsexuals","volume":"49","author":"Reutrakul","year":"1998","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2024032602355535000_bib20","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1054\/bjps.1999.3298","article-title":"Long-term outcome of augmentation mammaplasty in male-to-female transsexuals: a questionnaire survey of 107 patients","volume":"53","author":"Kanhai","year":"2000","journal-title":"Br J Plast Surg"},{"key":"2024032602355535000_bib21","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1080\/028443101300165354","article-title":"Augmentation mammaplasty in male-to-female trans-sexuals: facts and figures from Amsterdam","volume":"35","author":"Kanhai","year":"2001","journal-title":"Scand J Plast Reconstr Surg Hand Surg"},{"key":"2024032602355535000_bib22","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1055\/s-2005-865900","article-title":"Endocrine treatment of male-to-female transsexuals using Gonadotropin-Releasing Hormone agonist","volume":"113","author":"Dittrich","year":"2005","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"2024032602355535000_bib23","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s10508-005-7926-5","article-title":"Sexual and physical health after sex reassignment surgery","volume":"34","author":"De Cuypere","year":"2005","journal-title":"Arch Sex Behav"},{"key":"2024032602355535000_bib24","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ejim.2004.04.009","article-title":"Serum lipids and estrogen receptor gene polymorphisms in male-to-female transsexuals: effects of estrogen treatment","volume":"15","author":"Sosa","year":"2004","journal-title":"Eur J Intern Med"},{"key":"2024032602355535000_bib25","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1080\/15532739.2010.514222","article-title":"Analysis of Adulterated Silicone: implications for health promotion","volume":"12","author":"Wallace","year":"2010","journal-title":"Int J Transgenderism"},{"key":"2024032602355535000_bib26","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1097\/SMJ.0b013e3181684ae4","article-title":"Acute inflammatory response of the male breasts secondary to self-injection of petroleum jelly: a case report","volume":"101","author":"Chen","year":"2008","journal-title":"South Med J"},{"key":"2024032602355535000_bib27","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.jaad.2003.09.008","article-title":"Mycobacterium abscessus cellulitis and multifocal abscesses of the breasts in a transsexual from illicit intramammary injections of silicone","volume":"50","author":"Fox","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"2024032602355535000_bib28","first-page":"236","article-title":"Serum antinuclear antibodies in women with silicone breast implants","volume":"22","author":"Cu\u00e9llar","year":"1995","journal-title":"J Rheumatol"},{"key":"2024032602355535000_bib29","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1157\/13086628","article-title":"[Acute pneumonitis after subcutaneous injection of liquid silicone as a breast implant in a male-to-female transsexual]","volume":"42","author":"Sanz-Herrero","year":"2006","journal-title":"Arch Bronconeumol"},{"key":"2024032602355535000_bib30","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1080\/15563650701850025","article-title":"Subcutaneous silicone injection leading to multi-system organ failure","volume":"46","author":"Clark","year":"2008","journal-title":"Clin Toxicol (Phila)"},{"key":"2024032602355535000_bib31","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1097\/00006534-200103000-00013","article-title":"The devastating outcome of massive subcutaneous injection of highly viscous fluids in male-to-female transsexuals","volume":"107","author":"Hage","year":"2001","journal-title":"Plast Reconstr Surg"},{"key":"2024032602355535000_bib32","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1300\/J056v05n04_03","article-title":"Hormone treatment in transsexuals","volume":"5","author":"Asscheman","year":"1993","journal-title":"J Psychol Human Sex"},{"key":"2024032602355535000_bib33","article-title":"Breast care in the transgender individual","volume-title":"J Midwifery Womens Health","author":"Maycock","year":"2013"},{"key":"2024032602355535000_bib34","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1046\/j.1365-2265.2003.01821.x","article-title":"Endocrine intervention for transsexuals","volume":"59","author":"Levy","year":"2003","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2024032602355535000_bib35","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1080\/15532739.2011.700873","article-title":"Standards of care for the health of transsexual, transgender, and gender nonconforming people","volume":"13","author":"Coleman","year":"2011","journal-title":"Int J Transgenderism"},{"key":"2024032602355535000_bib36","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0303-7207(02)00105-3","article-title":"Breast cancer: from estrogen to androgen receptor","volume":"193","author":"Ando","year":"2002","journal-title":"Mol Cell Endocrinol"},{"key":"2024032602355535000_bib37","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/gye.16.2.113.120","article-title":"Testosterone and 5-dihydrotestosterone inhibit in vitro growth of human breast cancer cell lines","volume":"16","author":"Ortmann","year":"2002","journal-title":"Gynecol Endocrinol"},{"key":"2024032602355535000_bib38","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1210\/endo.140.1.6410","article-title":"Androgens down-regulate bcl-2 protooncogene expression in ZR-75-1 human breast cancer cells","volume":"140","author":"Lapointe","year":"1999","journal-title":"Endocrinology"},{"key":"2024032602355535000_bib39","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S1071-5576(00)00059-9","article-title":"Effects of an oral contraceptive combination with or without androgen on mammary tissues: a study in rats","volume":"7","author":"Jayo","year":"2000","journal-title":"J Soc Gynecol Investig"},{"key":"2024032602355535000_bib40","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1096\/fj.99-0863com","article-title":"Testosterone inhibits estrogen-induced mammary epithelial proliferation and suppresses estrogen receptor expression","volume":"14","author":"Zhou","year":"2000","journal-title":"FASEB J"},{"key":"2024032602355535000_bib41","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/01.GME.0000055522.67459.89","article-title":"A physiologic role for testosterone in limiting estrogenic stimulation of the breast","volume":"10","author":"Dimitrakakis","year":"2003","journal-title":"Menopause"},{"key":"2024032602355535000_bib42","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1677\/erc.1.01038","article-title":"Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition","volume":"12","author":"Kaaks","year":"2005","journal-title":"Endocr Relat Cancer"},{"key":"2024032602355535000_bib43","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/sj.bjc.6601517","article-title":"Postmenopausal levels of estrogen, androgen, and SHBG and breast cancer risk: long-term results of a prospective study","volume":"90","author":"Zeleniuch-Jacquotte","year":"2004","journal-title":"Br J Cancer"},{"key":"2024032602355535000_bib44","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1093\/jnci\/djr031","article-title":"Sex hormone levels and risks of estrogen receptor-negative and estrogen receptor-positive breast cancers","volume":"103","author":"Farhat","year":"2011","journal-title":"J Natl Cancer Inst"},{"key":"2024032602355535000_bib45","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.steroids.2011.02.029","article-title":"Endogenous oestrogens and breast cancer risk in premenopausal and postmenopausal women","volume":"76","author":"Key","year":"2011","journal-title":"Steroids"},{"key":"2024032602355535000_bib46","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/0022-4731(88)90295-6","article-title":"Androgenic activity of synthetic progestins and spironolactone in androgen-sensitive mouse mammary carcinoma (Shionogi) cells in culture","volume":"31","author":"Luthy","year":"1988","journal-title":"J Steroid Biochem"},{"key":"2024032602355535000_bib47","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1158\/0008-5472.CAN-11-3980","article-title":"Interactions of abiraterone, eplerenone, and prednisolone with wild-type and mutant androgen receptor: a rationale for increasing abiraterone exposure or combining with MDV3100","volume":"72","author":"Richards","year":"2012","journal-title":"Cancer Res"},{"key":"2024032602355535000_bib48","article-title":"Management of Turner syndrome (gonadal dysgenesis)","volume-title":"UpToDate","author":"Saenger","year":"2012"},{"key":"2024032602355535000_bib49","first-page":"1260","article-title":"Endocrine management of transsexual","volume":"80","author":"Futterweit","year":"1980","journal-title":"N Y State J Med"},{"key":"2024032602355535000_bib50","article-title":"Hormonal therapy of gender dysphoria: The male-to-female transsexual","volume-title":"Concepts in Transgender Identity","author":"Prior","year":"1998"},{"key":"2024032602355535000_bib51","doi-asserted-by":"crossref","first-page":"45","DOI":"10.4172\/1488-5069.1000006","article-title":"Towards optimal hormonal treatment of male to female gender identity disorder","volume":"1","author":"Basson","year":"2001","journal-title":"J Sex Reprod Med"},{"key":"2024032602355535000_bib52","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1300\/J485v09n03_06","article-title":"Physical aspects of transgender endocrine therapy","volume":"9","author":"Dahl","year":"2006","journal-title":"Int J Transgenderism"},{"key":"2024032602355535000_bib53","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1530\/eje.0.1450365","article-title":"A psycho-endocrinological overview of transsexualism","volume":"145","author":"Michel","year":"2001","journal-title":"Eur J Endocrinol"},{"key":"2024032602355535000_bib54","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1210\/er.2012-1008","article-title":"Progestogens used in postmenopausal hormone therapy: differences in their pharmacological properties, intracellular actions, and clinical effects","volume":"34","author":"Stanczyk","year":"2013","journal-title":"Endocr Rev"},{"key":"2024032602355535000_bib55","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1210\/edrv.20.3.0370","article-title":"Estrogen receptor null mice; what have we learned and where will they lead us?","volume":"20","author":"Couse","year":"1999","journal-title":"Endocr Rev"},{"key":"2024032602355535000_bib56","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1101\/gad.9.18.2266","article-title":"Mice lacking progesterone receptors exhibit pleiotropic reproductive abnormalities","volume":"9","author":"Lydon","year":"1995","journal-title":"Genes Dev"},{"key":"2024032602355535000_bib57","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1210\/jc.2006-1374","article-title":"Turner Syndrome Study Group: care of girls and women with Turner syndrome: a guideline of the Turner syndrome study Group","volume":"92","author":"Bondy","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2024032602355535000_bib58","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1023\/A:1015770423167","article-title":"Hormonal regulation of mammary differentiation and milk secretion","volume":"7","author":"Neville","year":"2002","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"2024032602355535000_bib59","doi-asserted-by":"crossref","first-page":"5076","DOI":"10.1073\/pnas.95.9.5076","article-title":"A paracrine role for the epithelial progesterone receptor in mammary gland development","volume":"95","author":"Brisken","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2024032602355535000_bib60","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/00000478-198606000-00003","article-title":"A correlative morphological study of human breasts and endometrium in the menstrual cycle","volume":"10","author":"Longacre","year":"1986","journal-title":"Am J Surg Pathol"},{"key":"2024032602355535000_bib61","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/jnci\/95.1.30","article-title":"Postmenopausal hormone therapy and change in mammographic density","volume":"95","author":"Greendale","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"2024032602355535000_bib62","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0378-5122(02)00006-3","article-title":"The meaning of mammographic breast density in users of postmenopausal hormonal therapy","volume":"41","author":"Speroff","year":"2002","journal-title":"Maturitas"}],"container-title":["The Journal of Sexual Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609515307591?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609515307591?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/11\/5\/1240\/48359122\/jsm_11_5_1240.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/11\/5\/1240\/48359122\/jsm_11_5_1240.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T03:06:09Z","timestamp":1711422369000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jsm\/article\/11\/5\/1240\/6958171"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,1]]},"references-count":62,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2014,5,1]]},"published-print":{"date-parts":[[2014,5,1]]}},"URL":"https:\/\/doi.org\/10.1111\/jsm.12487","relation":{},"ISSN":["1743-6109","1743-6095"],"issn-type":[{"value":"1743-6109","type":"electronic"},{"value":"1743-6095","type":"print"}],"subject":[],"published-other":{"date-parts":[[2014,5]]},"published":{"date-parts":[[2014,5,1]]}}}